Healthy Volunteers Clinical Trial
— HITPETNCT number | NCT01344928 |
Other study ID # | 95/180/2010 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | April 28, 2011 |
Last updated | April 28, 2011 |
The objectives of this study are to investigate the effects of short-time high-intensity interval training on tissue glucose and fat metabolism in healthy lean subjects and type 2 diabetic patients using modern and noninvasive imaging methods positron emission tomography (PET), magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS).
Status | Recruiting |
Enrollment | 0 |
Est. completion date | |
Est. primary completion date | |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 40 Years to 55 Years |
Eligibility |
Inclusion Criteria: The healthy patients 1. Age 40-55 2. BMI 18.5-30 3. Fasting plasma glucose less than 6.1 mmol/l 4. Normal glucose tolerance test (OGTT) The type 2 diabetic patients: 1. Age-, sex-, and BMI-matched with the study subjects in the phase 1 2. In a good treatment balance 3. Glycated haemoglobin (HbA1c) less than 7.5 mmol/l 4. Two hours glucose value in oral glucose tolerance test (OGTT) less than 10.0 mmol/l Exclusion Criteria: The healthy patients 1. Blood pressure > 140/90 mmHg 2. Any chronic disease 3. Any chronic medical defect or injury which hinder/interfere everyday life 4. History of anorexia nervosa or bulimia 5. History of rest or exercise-induced asthma 6. Previous use of anabolic steroids, additives or any other substrates 7. Smoking of tobacco, taking of snuffs, or use of narcotics. 8. Significant use of alcohol 9. Any other condition that in the opinion of the investigator could create a hazard to the subject safety, endanger the study procedures or interfere with the interpretation of study results 10. Presence of any ferromagnetic objects that would make MR imaging contraindicated 11. Current or history of regular and systematic exercise training 12. VO2max >40 ml/min/kg The type 2 diabetic patients: 1. Any other chronic disease than diabetes 2. Blood pressure > 140/90 mmHg 3. Any chronic medical defect or injury which hinder/interfere everyday life 4. History of anorexia nervosa or bulimia 5. History of rest or exercise-induced asthma 6. Smoking of tobacco, taking of snuffs, or use of narcotics. 7. Any other condition that in the opinion of the investigator could create a hazard to the subject safety, endanger the study procedures or interfere with the interpretation of study results 8. Presence of any ferromagnetic objects that would make MRI imaging contraindicated 9. Current or history of regular and systematic exercise training 10. VO2max >40 ml/ min/kg |
N/A
Country | Name | City | State |
---|---|---|---|
Finland | Turku PET Centre | Turku |
Lead Sponsor | Collaborator |
---|---|
Turku University Hospital | Academy of Finland, European Foundation for the Study of Diabetes, Helsinki University, Ministry of Education and Culture, Finland, Orion Farmos Research Foundation, Turku PET Centre, University of Turku, Verve Research, Oulu, Finland |
Finland,
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |